• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

For Consumers

  • Print
  • Share
  • E-mail

MedWatch Safety Alerts for Diabetes-related Drug/Biologic Products

FDA safety-related information, and MedWatch adverse event reporting program are critical in the treatment and care of patients with diabetes. MedWatch alerts provide timely new safety information on human drugs, medical devices, vaccines and other biologics, dietary supplements, and cosmetics.